TABLE 3.
Patient Demographics of 35 Spinal Cord Stimulation (SCS) Patients and Purchased Opioids and Neuropathic Pain Medications Divided Into 1-Year Periods
Mean daily opioid dose (MME) | Mean daily neuropathic medication dose (DDD) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Gender | Age | Site of pain | Years from trauma to SCS | –2 yr | –1 yr | +1 yr | +2 yr | –2 yr | –1 yr | +1 yr | +2 yr | |
Permanent 1 | Female | 43 | Left leg | 1 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 |
Permanent 2 | Male | 40 | Right leg | 2 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 |
Permanent 3 | Female | 52 | Right arm | 3 | 0 | 0 | 8 | 0 | 0.05 | 0 | 0.05 | 0.22 |
Permanent 4 | Female | 50 | Both arms | 4 | 0 | 0 | 78 | 203 | 0.18 | 0.33 | 0.58 | 0.64 |
Permanent 5 | Female | 46 | Left arm | 4 | 8 | 8 | 41 | 26 | 0.61 | 0 | 0 | 0 |
Permanent 6 | Female | 58 | Right arm | 7 | 44 | 59 | 51 | 51 | 0 | 0.01 | 0 | 0 |
Permanent 7 | Male | 83 | Right leg | 3 | 0 | 0 | 0 | 0 | 0.29 | 0.31 | 0.27 | 0.42 |
Permanent 8 | Male | 56 | Left arm | 4 | 0 | 0 | 0 | 0 | 0.20 | 0 | 0 | 0 |
Permanent 9 | Female | 47 | Right arm | 2 | 0 | 0 | 0 | 0 | 0.01 | 0.04 | 0 | 0 |
Permanent 10 | Female | 26 | Right leg | 3 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0 | 0 |
Permanent 11 | Female | 42 | Both legs | 13 | 0 | 0 | 0 | 0 | 0.27 | 0.46 | 0.92 | 0.49 |
Permanent 12 | Female | 58 | Left arm | 8 | 235 | 205 | 397 | 205 | 0.73 | 0.55 | 0.64 | 0.82 |
Permanent 13 | Female | 68 | Left leg | 8 | 0 | 0 | 0 | 0 | 0.19 | 0.15 | 0.13 | 0.13 |
Permanent 14 | Female | 60 | Right leg | 3 | 0 | 0 | 0 | 0 | 0.23 | 0.27 | 0.15 | 0 |
Permanent 15 | Male | 37 | Right arm | 4 | 0 | 0 | 0 | 66 | 0.05 | 0.05 | 0.35 | 0.40 |
Permanent 16 | Female | 47 | Right leg | 3 | 0 | 0 | 19 | 0 | 0.61 | 0.70 | 1.2 | 0.43 |
Permanent 17 | Male | 56 | Left arm | 9 | 0 | 88 | 159 | 237 | 0.90 | 1.0 | 1.0 | 0.15 |
Permanent 18 | Female | 61 | Right arm | 2 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 |
Permanent 19 | Female | 42 | Left leg | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Explanted 1 | Male | 44 | Right arm | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Explanted 2 | Female | 41 | Right arm | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Explanted 3 | Female | 51 | Right arm | 9 | 0 | 0 | 0 | 47 | 0.35 | 1.3 | 1.6 | 1.4 |
Explanted 4 | Male | 35 | Right leg | 2 | 10 | 6 | 4 | 0 | 0.72 | 0.91 | 0.92 | 0.26 |
Explanted 5 | Female | 16 | Left leg | 6 | 0 | 0 | 1 | 0 | 0.21 | 0 | 0 | 0 |
Explanted 6 | Male | 58 | Right arm | 6 | 0 | 0 | 60 | 0 | 0.17 | 0 | 0.12 | 0 |
Explanted 7 | Female | 32 | Left leg | 2 | 0 | 0 | 0 | 86 | 0 | 1.7 | 0.37 | 0.33 |
Explanted 8 | Female | 49 | Right leg | 4 | 88 | 66 | 29 | 26 | 1.2 | 1.0 | 0.79 | 0.61 |
Trial 1 | Female | 54 | Right arm | 3 | 0 | 0 | 0 | 0 | 0.55 | 0.50 | 0.68 | 0.45 |
Trial 2 | Female | 56 | Right leg | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trial 3 | Male | 58 | Left leg | 2 | 0 | 0 | 0 | 0 | 0.06 | 0.04 | 0 | 0 |
Trial 4 | Female | 59 | Left arm | 9 | 183 | 180 | 155 | 180 | 0.85 | 0.58 | 0.96 | 1.4 |
Trial 5 | Female | 28 | Pelvis | 1 | 0 | 3 | 10 | 5 | 0.12 | 0 | 0.25 | 0.50 |
Trial 6 | Male | 65 | Left arm | 2 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 |
Trial 7 | Female | 52 | Right arm | 5 | 0 | 0 | 0 | 0 | 0.52 | 0.63 | 0.58 | 0.57 |
Trial 8 | Male | 60 | Right leg | 1 | 0 | 2 | 2 | 0 | 0.04 | 0.88 | 0.87 | 0.69 |
Summary (mean ± SD) | 49 ± 13 | 4.3 ± 2.9 | 16 ± 51 | 18 ± 48 | 29 ± 75 | 32 ± 67 | 0.13 ± 0.40 | 0.20 ± 0.53 | 0.16 ± 0.47 | 0.15 ± 0.44 |
Mean daily opioid dose (MME) = mean daily opioid dose purchased in morphine milligram equivalent (MME) during a 1-yr periods related to the SCS implantation date; mean daily neuropathic medication dose (DDD) = mean daily neuropathic medication purchased in defined daily dose (DDD) during a 1-yr periods related to the SCS implantation date; permanent = SCS implanted and in use throughout the follow-up period; explanted = SCS implanted but explanted before the end of the follow-up; trial = SCS trial only.